w 7 has been researched along with beta-endorphin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beaubien, BC; Herbert, E | 1 |
| Albrizio, M; Bagorda, A; Casavola, V; Di Sole, F; Guerra, L; Minoia, P; Reshkin, SJ | 1 |
2 other study(ies) available for w 7 and beta-endorphin
| Article | Year |
|---|---|
Modulation of beta-endorphin secretion from mouse pituitary tumor cells by calmodulin inhibitor W7.
Topics: Animals; beta-Endorphin; Calmodulin; Cell Line; Kinetics; Mice; Pituitary Neoplasms; Sulfonamides | 1986 |
Naloxone inhibits A6 cell Na(+)/H(+) exchange by activating protein kinase C via the mobilization of intracellular calcium.
Topics: Animals; beta-Endorphin; Calcium; Calcium Signaling; Cell Line; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Enzyme Inhibitors; Hydrogen-Ion Concentration; Naloxone; Naphthalenes; Narcotic Antagonists; Protein Kinase C; Receptors, Opioid, mu; Sodium-Hydrogen Exchangers; Spectrometry, Fluorescence; Sulfonamides | 2001 |